Natural remedies in the treatment of health conditions are an appealing option for many individuals. Previous studies reported that fermented and unfermented rooibos tea have considerable anti-inflammatory and antioxidative properties. Most of this knowledge, however, originates from animal and cell culture studies. The aims of this review are to evaluate the existing, but limited, body of knowledge regarding rooibos tea interventions in humans and to identify the gaps in the literature. The PRISMA extension for Scoping Reviews (PRISMA-ScR) guidelines were followed in the collation of this scoping review. Among the databases searched were Google Scholar, PubMed, Cochrane Library, Scopus, and Web of Science. This review comprised 18 publications, with half (50%) of the studies being conducted in South Africa. There were 488 participants in all, ranging in age from six to 83 years, in the investigations. Rooibos tea was either fermented, unfermented, or black in 62% of the studies. Doses ranging from 200 to 1,200 ml were employed. In both healthy and at-risk individuals, rooibos has been shown to enhance lipid profiles, boost antioxidant status, and lower blood glucose levels. The existing findings suggests that rooibos consumption demonstrated to improve lipid profiles, boost antioxidant status, and lower blood glucose levels in both apparently healthy, and individual at-risk individuals or diagnosed of chronic conditions. Thus, it can be presumed that rooibos tea provides some health benefits, yet these findings are based on a limited number of human intervention studies and a small total sample size. Additionally, a variety of rooibos dosages and types of tea in the experiments had inconsistent results that were probably impacted by the amount consumed. Future studies should include a dose-response study in humans, as well as large scaled clinical trials to evaluate the health effects of Rooibos.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10774856 | PMC |
http://dx.doi.org/10.4081/jphia.2023.2784 | DOI Listing |
Med J Malaysia
January 2025
Nanobiomedicine lab, Centre for Global Health Research, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, Tamilnadu, India.
Introduction: Zinc oxide nanoparticles (ZnO NPs) exhibit a wide range of biomedical applications majorly used as antiinflammatory, anti-cancer, anti-diabetic, and anti-microbial activity and other biomedical applications because they show less toxicity and are very compatible. Zinc metal is an inorganic and essential element in the human body at the trace level. ZnO NPs are also GRAS substances (Generally Recognized As Safe).
View Article and Find Full Text PDFCurr Drug Metab
December 2024
Nutrition and Food Security Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
The well-established calcineurin inhibitor, tacrolimus, as an immunosuppressive agent, is widely prescribed after organ transplantation. Cytochrome P450 (CYP 450) isoforms are responsible for the metabolism of many features associated with food parameters like phytochemicals, juices, and fruits. This review article summarizes the findings of previous studies to help predict the efficacy or side effects of tacrolimus in the presence of food variables.
View Article and Find Full Text PDFNat Prod Res
January 2025
Department of Biochemistry and Biotechnology, Faculty of Life Sciences, The Women University Multan, Multan, Pakistan.
Orientin is one of the flavonoid glycosides with diverse biological properties such as anticancer, antioxidant, neuroprotective, cardioprotective, antiallergic, and anti-inflammatory. It is found in several plants like rooibos tea, , , , and species. This review aimed to summarise the various medicinal properties of the orientin focusing on its underlying molecular mechanism reported based on and studies.
View Article and Find Full Text PDFMol Nutr Food Res
January 2025
Applied Microbial and Health Biotechnology Institute, Cape Peninsula University of Technology, Cape Town, South Africa.
The world is experiencing a demographic shift toward an increasing proportion of elderly persons. Alzheimer's disease (AD) and other neurological disorders are far more likely to develop as people age. AD is a gradual, irreversible, and degenerative brain disorder that progressively deteriorates memory and cognitive function, eventually leading to death.
View Article and Find Full Text PDFEnviron Sci Technol
December 2024
Australian Rivers Institute, Centre for Marine and Coastal Research, Griffith University, Nathan, QLD 4111, Australia.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!